论文部分内容阅读
目的分析艾滋病抗病毒治疗(ART)病例的死亡情况,探讨相关影响因素。方法对河北省2004-2013年死亡的艾滋病ART病例资料进行回顾性总结分析。结果截至2013年12月31日,共有229例治疗病例死亡,71.2%死于艾滋病相关疾病。男性病例占62.4%;40～49岁组病人占38.9%;经血途径感染者占40.6%,经性途径感染者占52.0%;农民占64.6%;初中及以下占81.2%;已婚或同居有配偶者占66.4%。40.2%的病例治疗前CD+4T淋巴细胞(简称CD4细胞)计数<50个/μL,且其中50%病例在3个月内死亡;而治疗前CD4细胞计数>200个/μL的病例占死亡总数13.5%,仅22.6%在3个月内死亡。经血液途径感染者中,69.9%的病例生存时间超过3个月,经性途径感染的病例中,50.4%在3个月内死亡。结论治疗延迟是导致艾滋病病人死亡的主要原因,早期治疗能降低艾滋病病死率。
Objective To analyze the deaths of AIDS patients with ART and explore the related factors. Methods Retrospective analysis was made on the data of ART cases of AIDS deaths in Hebei Province from 2004 to 2013. Results As of December 31, 2013, a total of 229 treatment cases were fatal and 71.2% died of AIDS-related diseases. Male cases accounted for 62.4%; 40-49-year-old group of patients accounted for 38.9%; menstrual pathogen infected 40.6%, sexually transmitted infections accounted for 52.0%; farmers accounted for 64.6%; junior high school and below accounted for 81.2%; married or living Spouses accounted for 66.4%. 40.2% of cases had counts of CD + 4T lymphocytes (CD4 cells for short) <50 cells / μL before treatment, and 50% of them died within 3 months; before treatment, CD4 cells count> 200 cells / μL accounted for the death The total number of 13.5%, only 22.6% died within 3 months. Of those infected by the bloodstream, 69.9% of the patients survived for more than 3 months and 50.4% of those infected by the sexual route died within 3 months. Conclusion Delay in treatment is the leading cause of AIDS death, early treatment can reduce AIDS mortality.